MAXCYTE, INC.
MXCTdata completeness 88%7 fiscal years on fileData notes: no data for concept 'totalDebt'
MAXCYTE, INC. earns about -19% on invested capital, but has diluted owners by 17% over 5 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $21.6M1 | $28.7M2 | $19.5M3 | $22.2M4 | $21M4 |
| Net income | −$19.1M5 | −$23.6M6 | −$37.9M7 | −$41.1M8 | −$44.6M8 |
| Operating cash flow | −$10.7M9 | −$14.8M10 | −$21.7M11 | −$27.6M12 | −$34.4M12 |
| Capital expenditure | $3.83M13 | $18.5M14 | $3.7M15 | $1.65M16 | $1.77M16 |
| Free cash flow (derived) | −$14.5M9 | −$33.3M10 | −$25.4M11 | −$29.3M12 | −$36.2M12 |
| Total debt | — | — | — | — | — |
| Cash & equivalents | $47.8M17 | $11.1M18 | $46.5M19 | $27.9M20 | $20.1M20 |
| Diluted shares | 90.6M | 101.7M | 103.3M | 104.8M | 106.4M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $16.11 of net worth that earned you −$4.19 and generated −$3.4 of cash last year.
It earned an average -19% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 17% over 5 years — owners have been diluted. Worth asking what they got for it.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-12-31 · accession 0001558370-23-003911 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0001558370-24-003001 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-12-31 · accession 0001558370-25-002721 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2024-12-31 · accession 0001104659-26-034557 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2021-12-31 · accession 0001558370-23-003911 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001558370-24-003001 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001558370-25-002721 (NetIncomeLoss)
- 10-K · period ending 2024-12-31 · accession 0001104659-26-034557 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001558370-23-003911 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001558370-24-003001 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001558370-25-002721 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-12-31 · accession 0001104659-26-034557 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0001558370-23-003911 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0001558370-24-003001 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-31 · accession 0001558370-25-002721 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2024-12-31 · accession 0001104659-26-034557 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2021-12-31 · accession 0001558370-23-003911 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0001558370-24-003001 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001558370-25-002721 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001104659-26-034557 (CashAndCashEquivalentsAtCarryingValue)